Systemic Lymphadenectomy Cannot Be Recommended for Low‐Risk Corpus Cancer
Open Access
- 1 January 2010
- journal article
- research article
- Published by Wiley in Obstetrics and Gynecology International
- Vol. 2010 (1) , 490219
- https://doi.org/10.1155/2010/490219
Abstract
Objective. The objective of this study is to ascertain whether omission of lymphadenectomy could be possible when uterine corpus cancer is considered low‐risk based on intraoperative pathologic indicators. Patient and Methods. Between 1998 and 2007, a total of 83 patients with low risk corpus cancer (endometrioid type, grade 1 or 2, myometrial invasion ≦50%, and no intraoperative evidence of macroscopic extrauterine spread, including pelvic and paraaortic lymph node swelling and adnexal metastasis) underwent the total abdominal hysterectomy and bilateral salpingo‐oophorectomy without lymphadenectomy. A retrospective review of the medical records was performed, and the disease‐free survival (DFS), overall survival (OS), peri‐ and postoperative morbidities and complications were evaluated. Results. The 5‐year DFS rates and the 5‐year OS rates were 97.6% and 98.8%, respectively. No patient presented postoperative leg lymphedema and deep venous thrombosis. Conclusion. Omission of lymphadenectomy did not worsen the DFS or OS. The present findings suggest that systemic lymphadenectomy could be omitted in low‐risk endometrial carcinoma.Keywords
This publication has 31 references indexed in Scilit:
- Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised studyThe Lancet, 2008
- The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histologyInternational Journal of Gynecologic Cancer, 2008
- Omission of lymphadenectomy is possible for low-risk corpus cancerEuropean Journal of Surgical Oncology, 2007
- Surgical Staging for Patients Presenting With Grade 1 Endometrial CarcinomaObstetrics & Gynecology, 2005
- Predictors of final histology in patients with endometrial cancerGynecologic Oncology, 2004
- Endometrial cancer: predictors of peritoneal failure☆☆Supported by the Mayo Cancer Center (P30CA15083) and the Rochester Research Committee, Mayo Foundation. Presented at the 33rd Annual Meeting of the Society of Gynecologic Oncologists, Miami Beach, FL, March 16 to 20, 2002.Gynecologic Oncology, 2003
- Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter StudyGynecologic Oncology, 2000
- Lymph Node Sampling and Survival in Endometrial CancerGynecologic Oncology, 1998
- Good Outcome Associated with a Standardized Treatment Protocol Using Selective Postoperative Radiation in Patients with Clinical Stage I Adenocarcinoma of the EndometriumGynecologic Oncology, 1995
- Detection and patterns of treatment failure in 300 consecutive cases of “early” endometrial cancer after primary surgeryGynecologic Oncology, 1992